Smartlens

Mountain View, United States Founded: 2015 • Age: 11 yrs
Non-invasive devices for eye pressure measurement are provided by Smartlens.

About Smartlens

Smartlens is a Healthcare company based in Mountain View (United States) founded in 2015 by Murat Baday, Savas Komban, and Sevda Agaoglu. It operates as a non-invasive devices for eye pressure measurement are provided by Smartlens. Smartlens has raised $11.3 million across 2 funding rounds from investors including Leland Stanford Junior University, Wilson Sonsini Goodrich & Rosati and Ambit Health Ventures. Its chief executive is Savas Komban. Smartlens offers products and services including miLens, Slit IQ, THERx IQ, and miLens IQ+. Its focus areas include HealthTech, Disease Self Management, Ophthalmology and Monitoring. Its legal entity is Smartlens, Inc. Its competitors include Spect, Okko Health, Myopia, Color Blind Check and Easee and 1 more; 2 of its 6 listed competitors have raised funding.

Company details

Smartlens was founded in 2015 and is based in Mountain View, United States. Operations focus on the health technology sector, where non-invasive devices for intraocular pressure (IOP) measurement are developed and provided. The flagship product, miLens, supports glaucoma management through accurate, contactless assessments. Services target healthcare professionals and patients requiring routine eye health monitoring in clinical settings.

  • Headquarters Mountain View, United States
  • Founders Murat Baday, Savas Komban, Sevda Agaoglu
  • Sectors
    Healthcare
  • Website smartlens.health
  • Social LinkedIn X
  • Legal Name Smartlens, Inc.
Key Metrics

Products & Services of Smartlens

Smartlens offers a comprehensive portfolio of products and services, including miLens, Slit IQ, THERx IQ, and miLens IQ+.

miLens
Medical Device

Non-invasive device for remote intraocular pressure monitoring.

Slit IQ
AI Platform

Smartphone-based system for remote anterior segment eye exams.

THERx IQ
Wearable Device

Automated system for precise medication delivery in eye diseases.

miLens IQ+
AI Analytics Platform

Integrates data for insights on eye disease progression.

Funding Insights of Smartlens

Smartlens has successfully raised a total of $11.3M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $5.2 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $11.3M
  • Total Rounds 2
  • Last Round Series A β€” $5.2M
  • First Round $6.1M

    (Jul 2023)

  • Investors Count 9

All 2 funding rounds of Smartlens with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2025$5.2MSeries A–Ambit Health Ventures
Jul 2023$6.1MSeries A–Ambit Health Ventures
Valuation history

9 investors in total: 9 institutional.

Investors in Smartlens

Smartlens has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Leland Stanford Junior University, Wilson Sonsini Goodrich & Rosati and Ambit Health Ventures.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
-
–ambithealthventures.com-
US early-stage tech startups are funded by Graphene Ventures.
–graphenevc.comPalo Alto, United States
-
–plaisancecap.com-
Tech & Life Science focused early & growth stage VC firm investing in the US & China
–3ebiovc.comBeijing, China
A venture capital firm focused on healthcare and life sciences.
–boutiquevc.comPalo Alto, United States
-
–hbsangelsny.com-
Various courses and degrees across diversified streams are offered.
1876stanford.eduUnited States
Provider of legal services to technology and life science companies
1961wsgr.comPalo Alto, United States
Venture capital funding is offered for innovative health projects.
–sophincap.com-
Premium access

Investor details for Smartlens

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Smartlens

19 people are tracked at Smartlens (5 in leadership, 12 in board & advisors, 2 in team).

NameRoleGroup
Murat Baday
Co-FounderLeadership
Savas Komban
Co-Founder & CEOLeadership
Sevda Agaoglu
Co-FounderLeadership
Ahmet Taylan Yazici
Co-Founder & CMOLeadership
Steve Klein
Head of Collaboration & GrowthLeadership
James J Song
AdvisorBoard & advisors
Robert Stamper
AdvisorBoard & advisors
James Tsai
AdvisorBoard & advisors
Ismail Emre Araci
Co-Founder & Scientific AdvisorBoard & advisors
Ike Ahmed
AdvisorBoard & advisors
Vince Anido
AdvisorBoard & advisors
Richard Lindstrom
AdvisorBoard & advisors
Adrienne Graves
AdvisorBoard & advisors
Robert Chang
AdvisorBoard & advisors
Michael Kass
AdvisorBoard & advisors
Ehsan Sadri
AdvisorBoard & advisors
Sam Goldberger
Board ObserverBoard & advisors
Lee Kramm
Regulatory LeadTeam
Gary Mocnik
Quality AssuranceTeam
Premium access

Complete people profiles for Smartlens

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Smartlens

3 dated milestones of Smartlens across 10 years, from founding to its latest funding, stage changes and deals.

  1. Founded Smartlens is founded.
  2. Funding First funding round of $6.1M.
  3. Funding Latest funding round, Series A, of $5.2M.

Competitors of Smartlens

Smartlens has 6 listed competitors in our database, 2 of them funded. They include Spect, Okko Health, Myopia, Color Blind Check and Easee, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
getspect.com2017San Francisco, United States$1.68M–
Digital solutions for early ophthalmic disease diagnosis are developed.
okkohealth.com2019Bristol, United Kingdom$2.8M16
Eye health is monitored at home using a specialized app.
myopia.app2018Aguilas, Spain––
Myopia prevention app monitors family screen habits and distances.
colorblindcheck.com2014Regensdorf, Switzerland––
Offers a mobile app to check for color blindness.
easee.online2016Amsterdam, Netherlands––
App for eye test
visualacuity.info2018Wakerley, Australia––
Delivers software solutions for visual care and diagnostics.
Premium access

Detailed competitors of Smartlens

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Health Monitoring & Wearables

10 companies that operate in the same segment as Smartlens (Health Monitoring & Wearables), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Smart fitness equipment and streaming platforms are provided.
2011New York, New York, United StatesUSD 995.53 MUSD 2.45 B2,894
Connected devices for health, sleep, and activity monitoring are developed.
2008Moulineaux, Seine-maritime, FranceUSD 93.83 M––
Internet first brand offering wearable breast pumps
2013London, England, United KingdomUSD 157.63 M––
Metabolic health is tracked via devices and fitness platforms.
2019Bengaluru, Karnataka, IndiaUSD 163.28 MUSD 65.48 M274
Health-tracking smart rings and biosensors are developed for biometric monitoring.
2013Oulu, North Ostrobothnia, FinlandUSD 1.32 BUSD 398.5 M1,632
Wearable glucose monitoring patches are provided for real-time data tracking.
1999San Diego, California, United StatesUSD 52.5 MUSD 4.66 B10,300
AI-based mobile app tracks and predicts menstrual cycles.
2015London, England, United KingdomUSD 269 MUSD 275.25 M701
Smartphone-enabled glucometers and diabetes management apps are provided.
2015Delhi, Delhi, IndiaUSD 50.83 MUSD 2.74 M142
Provider of a fertility tracking app that doubles as birth control
2013Stockholm, SwedenUSD 99.5 M––
Diabetes management is enabled via glucose meters and mobile apps.
2010Palo Alto, California, United StatesUSD 201 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Smartlens

Premium access

Complete news archive for Smartlens

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Smartlens

Smartlens was founded in 2015 and raised its 1st funding round 8 years after it was founded.

Smartlens is headquartered in Mountain View, United States. It is registered at Mountain View, California, United States.

Savas Komban is the current CEO of Smartlens. They have also founded this company.

Smartlens is a funded company, having raised a total of $11.3M across 2 funding rounds to date. The company's 1st funding round was a Series A of $6.1M, raised on Jul 2023.

Smartlens was founded in 2015 and is based in Mountain View, United States. Operations focus on the health technology sector, where non-invasive devices for intraocular pressure (IOP) measurement are developed and provided. The flagship product, miLens, supports glaucoma management through accurate, contactless assessments. Services target healthcare professionals and patients requiring routine eye health monitoring in clinical settings.

Smartlens's top competitors include Okko Health, Spect and Myopia.

Smartlens offers miLens, Slit IQ, THERx IQ, and miLens IQ+.

Smartlens has 9 investors. Key investors include Leland Stanford Junior University, Wilson Sonsini Goodrich & Rosati, Ambit Health Ventures, Graphene Ventures, and Sophia Innovation Capital.

Smartlens operates through Smartlens, Inc..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available